Imavita is investing in its own research in the following subjects:

• Cardiovascular Disease
• Osteo-articular Pathologies
• Dermatology
• Oncology
• Neurology
• Drug Disposition / Pharmacokinetics (PK) imaging

Imavita is an Innovative Young Company (JEI / “Jeune Entreprise Innovante“).

Imavita has Research Tax Credit agreement / CIR (“Crédit Impôt Recherche“) for years 2016 to 2020 (obtained on April 22th 2016 / download pdf file of Research Tax Credit Accreditation).

This agreement, obtained from the french authorities, permits to the clients working with Imavita to refund R&D spendings to their corporate taxes.

See the following links for more informations on CIR / Research Tax Credit: MESR (Ministère de l’Enseignement Supérieur et de la Recherche).